An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging ...

The BC Cancer Foundation is launching a fundraising campaign to support the next three years of immunotherapy research at BC ...

New antibody AHA-1031 shows potential in treating non small cell lung cancer resistant to immunotherapy, offering new hope.

John Ryan, a U.S. Navy veteran, beat cancer through nearly a decade of experimental immunotherapy treatment. The vet shared ...

Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

Russian mRNA cancer 'vaccine' shows promise in pre-clinical trials, part of growing immunotherapy trend in cancer treatment.

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

The new vaccine is "personalized," meaning it is designed to train the patient's immune system to recognize and eliminate any remaining cells of that person's cancer.

The Cancer Vaccines Market is witnessing significant expansion, driven by rising cancer prevalence and advancements in ...

BofA has initiated coverage of Candel Therapeutics (CADL) with a buy rating, citing the potential of its immunotherapy drug candidates CAN-2409 and CAN-3110. Read more here.

Mayo Clinic, Mount Sinai and Huntsman Cancer Insitute are delivering services from chemotherapy to imaging in cancer patients ...

The event featured discussions centered on advancements in multidisciplinary treatments, precision medicine and ...